P

    Pennant Group Inc (PNTG)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $36.76
    -0.32 (-0.86%)

    Market Cap: $1.30B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    72%(21/29)
    Avg Surprise
    +1.84%
    Streak
    13 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.35
    Range$0.33 - $0.37
    7 analysts
    EPS Revisions
    3
    0
    7d
    3
    0
    30d
    EPS Estimate Drift
    90d ago$0.34-3.2%
    60d ago$0.34-3.2%
    30d ago$0.34-2.8%
    7d ago$0.35-1.2%
    Current$0.35
    Revenue Consensus
    $299M
    Range$297M - $303M
    6 analysts
    Dec 31, 2026
    EPS Consensus$0.41
    Range$0.39 - $0.43
    7 analysts
    Revenue Consensus
    $314M
    Range$311M - $318M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.41---
    Sep 26EST
    		-$0.35---
    Jun 26
    		$0.29$0.28+3.57%Beat+7.4%
    Mar 26
    		$0.32$0.31+3.23%Beat+18.5%
    Dec 25
    		$0.34$0.32+7.70%Beat+41.7%
    Sep 25
    		$0.25$0.24+4.17%Beat-3.8%
    Jun 25
    		$0.27$0.27+0.00%Beat+12.5%
    Mar 25
    		$0.27$0.24+12.50%Beat+35.0%
    Dec 24
    		$0.24$0.24+0.00%Beat+9.1%
    Sep 24
    		$0.26$0.23+13.04%Beat+30.0%
    Jun 24
    		$0.24$0.22+9.09%Beat+33.3%
    Mar 24
    		$0.20$0.17+17.65%Beat+53.8%
    Dec 23
    		$0.22$0.22+0.00%Beat+22.2%
    Sep 23
    		$0.20$0.19+5.26%Beat+42.9%
    Jun 23
    		$0.18$0.16+12.50%Beat+28.6%
    Mar 23
    		$0.13$0.14-7.14%Miss+30.0%
    Dec 22
    		$0.18$0.18+0.00%Beat+157.1%
    Sep 22
    		$0.14$0.18-22.22%Miss+27.3%
    Jun 22
    		$0.14$0.14+0.00%Beat-17.6%
    Mar 22
    		$0.10$0.08+25.00%Beat-9.1%
    Dec 21
    		$0.07N/A-53.33%Miss-58.8%
    Sep 21
    		$0.11$0.18-38.89%Miss-38.9%
    Jun 21
    		$0.17$0.21-19.05%Miss-29.2%
    Mar 21
    		$0.11$0.19-42.11%Miss-31.3%
    Dec 20
    		$0.17$0.20-15.00%Miss+6.3%
    Sep 20
    		$0.18$0.17+5.88%Beat+12.5%
    Jun 20
    		$0.24$0.12+100.00%Beat+166.7%
    Mar 20
    		$0.16$0.13+23.08%Beat-
    Dec 19
    		$0.16$0.16+0.00%Beat-
    Sep 19
    		$0.16$0.12+33.33%Beat-
    Jun 19
    		$0.09$0.12-25.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio30.63EV/EBITDA24.51x
    Price/FCF36.92xFCF Yield2.71%
    Profitability
    Profit Margin2.93%Operating Margin6.19%
    ROE10.40%ROIC8.26%
    Financial Health
    Debt/Equity0.55xInterest Coverage5.89x
    Current Ratio1.20xQuick Ratio1.20x
    Trading Statistics
    Beta1.29Avg Volume277.84K
    52-Week High$42.6952-Week Low$22.25

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$38.35
    SMA 20$38.62
    SMA 50$38.98
    SMA 200$32.85
    EMA 10$38.06
    EMA 20$38.56
    EMA 50$38.14
    EMA 200$33.64

    MACD

    Line: -0.44Signal: -0.15Hist: -0.29

    ADX

    ADX: 17.6+DI: 15.0-DI: 23.6

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$40.08

    Bollinger Bands

    Upper Band$40.09
    Lower Band$37.14
    %B Position765%(Upper)
    Band Width-0.13

    RSI (14-Day)

    Neutral
    33.3

    Momentum Oscillators

    Stoch %K7.5
    Stoch %D13.1
    Williams %R-92.9
    ROC (10d)-6.2%
    Momentum-2.42
    CCI (20d)-268.0
    MFI (14d)33.2

    Volatility Measures

    ATR (14d)$1.24(3.4%)
    StdDev (20d)0.74
    Hist Vol23.7%(Moderate)

    Volume Flow

    VWAP$36.83
    OBV10.5M
    AD Line4.1M
    CMF (20d)-0.176

    Volume Metrics

    Avg Vol (20d)279.0K
    Vol Ratio1.0x
    VWMA (20d)$38.60

    Pivot Points

    R3$39.02
    R2$38.61
    R1$37.85
    Pivot Point$37.44
    S1$36.67
    S2$36.26
    S3$35.50

    Advanced Oscillators

    TSI-13.16
    Ultimate Osc30.9
    KST-38.30

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$297.98M$285.36M$289.32M$229.04M$219.50M$209.84M$188.89M$180.69M$168.75M$156.91M$145.95M$140.19M
    Cost of Revenue$242.63M$232.66M$237.05M$185.43M$177.28M$168.75M$152.67M$144.47M$135.31M$126.00M$116.93M$112.38M
    Gross Profit$55.35M$52.70M$52.27M$43.61M$42.23M$41.10M$36.22M$36.22M$33.43M$30.92M$29.02M$27.81M
    Operating Expenses$38.16M$35.40M$34.80M$33.37M$30.70M$28.45M$26.98M$25.43M$23.87M$22.40M$21.45M$20.75M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$21.61M$19.69M$19.34M$19.30M$17.60M$14.84M$13.87M$13.02M$11.88M$11.44M$9.75M$9.42M
    Operating Income$17.19M$17.30M$17.47M$10.24M$11.53M$12.65M$9.24M$10.79M$9.56M$8.52M$7.57M$7.06M
    Interest Income$370,000$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$3.35M$3.07M$3.25M$1.02M$1.20M$1.21M$650,000$2.89M$1.62M$1.79M$1.57M$1.50M
    Income Before Tax$14.83M$14.09M$14.27M$9.40M$10.58M$11.38M$8.60M$8.01M$7.94M$6.82M$6.31M$5.53M
    Income Tax Expense$3.94M$3.79M$3.90M$2.52M$2.60M$2.85M$2.07M$1.35M$1.84M$1.76M$1.78M$1.07M
    Net Income$10.90M$10.29M$10.38M$6.89M$7.98M$8.52M$6.53M$6.66M$6.09M$5.06M$4.53M$4.46M
    EBITDA$21.22M$20.08M$20.12M$12.70M$14.22M$14.69M$11.30M$13.01M$11.16M$10.07M$9.32M$8.48M
    EBIT$17.81M$17.16M$17.52M$10.42M$11.78M$12.58M$9.25M$10.90M$9.56M$8.61M$7.88M$7.02M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PNTG

    News

    3 Reasons Why Growth Investors Shouldn't Overlook The Pennant Group (PNTG)

    The Pennant Group (PNTG) is presented as a strong growth stock for investors due to its solid growth attributes, including impressive earnings and sales growth, and efficient asset utilization. The company boasts a favorable Zacks Growth Score and a strong Zacks Rank, further supported by positive earnings estimate revisions. These factors suggest that PNTG could potentially outperform the market.

    qz.com•8/25/26•
    Bullish

    RBC Capital Maintains Pennant Group(PNTG.US) With Buy Rating, Raises Target Price to $44

    RBC Capital has reiterated its Buy rating for Pennant Group (PNTG.US) and increased its price target to $44. This reflects the firm's continued confidence in the company's financial prospects and market performance.

    Moomoo•8/21/26•
    Bullish

    Pennant group chief clinical officer sells $53,699 in stock

    Pennant Group's Chief Clinical Officer, Jason Paul Steik, recently sold 1,394 shares of company stock for a total of $53,699. This transaction follows strong stock performance, with PNTG shares up 55.66% over the past year and 39.68% year-to-date, although the stock appears overvalued according to InvestingPro analysis. The company also recently reported strong Q2 2026 financial results, surpassing analyst expectations, and received a raised price target from Wells Fargo.

    Investing.com•8/16/26•
    Neutral

    Will Pennant’s Higher 2026 Guidance and Tucson Acquisition Change Pennant Group's (PNTG) Narrative

    The Pennant Group reported strong Q2 2026 results, including increased sales and net income, and raised its 2026 revenue guidance to US$1.17 billion to US$1.19 billion. The company also expanded its senior living portfolio with the acquisition of River Centre Assisted Living in Tucson, Arizona. While these moves indicate growth, they also increase execution risk due to existing debt and thin profit margins, leading to mixed fair value estimates from analysts.

    Simply Wall Street•8/14/26•
    Somewhat-Bullish

    Will Pennant’s Higher 2026 Guidance and Tucson Acquisition Change Pennant Group's (PNTG) Narrative

    The Pennant Group (PNTG) reported strong Q2 2026 results with increased sales and net income, along with higher 2026 revenue guidance of US$1.17 billion to US$1.19 billion. The company also expanded its senior living portfolio by acquiring the River Centre Assisted Living community in Tucson. This strategic move supports Pennant's growth narrative through network expansion, though it also introduces execution risk due to existing debt and thin profit margins.

    Simply Wall Street•8/14/26•
    Somewhat-Bullish

    Frequently Asked Questions About PNTG

    Does PNTG pay dividends?
    Pennant Group Inc (PNTG) does not currently pay a regular dividend.
    What is PNTG's P/E ratio?
    Pennant Group Inc has a price-to-earnings (P/E) ratio of 30.63.
    What is PNTG's market cap?
    Pennant Group Inc (PNTG) has a market capitalization of $1.30B with a current stock price of $36.76.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In